Si-Hong Lu

863 total citations
10 papers, 677 citations indexed

About

Si-Hong Lu is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Si-Hong Lu has authored 10 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Pathology and Forensic Medicine and 3 papers in Cancer Research. Recurrent topics in Si-Hong Lu's work include Cancer Cells and Metastasis (5 papers), Cancer Mechanisms and Therapy (3 papers) and Microfluidic and Bio-sensing Technologies (3 papers). Si-Hong Lu is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Cancer Mechanisms and Therapy (3 papers) and Microfluidic and Bio-sensing Technologies (3 papers). Si-Hong Lu collaborates with scholars based in China, Taiwan and United States. Si-Hong Lu's co-authors include Tianfu Li, Ying Lin, Huijuan Zeng, Yunjian Zhang, Ying Chang, Jiong Bi, Wen‐Sy Tsai, Qi Zhang, Xueke Qian and Liang Yu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biomaterials.

In The Last Decade

Si-Hong Lu

10 papers receiving 663 citations

Peers

Si-Hong Lu
Denisa Dragu Romania
Eun Jeong Cho South Korea
Chirayu Patel United States
Sharon Glaysher United Kingdom
Paul Kurywchak United States
Jinlu Ma China
Diego M. Avella United States
Denisa Dragu Romania
Si-Hong Lu
Citations per year, relative to Si-Hong Lu Si-Hong Lu (= 1×) peers Denisa Dragu

Countries citing papers authored by Si-Hong Lu

Since Specialization
Citations

This map shows the geographic impact of Si-Hong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Si-Hong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Si-Hong Lu more than expected).

Fields of papers citing papers by Si-Hong Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Si-Hong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Si-Hong Lu. The network helps show where Si-Hong Lu may publish in the future.

Co-authorship network of co-authors of Si-Hong Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Si-Hong Lu. A scholar is included among the top collaborators of Si-Hong Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Si-Hong Lu. Si-Hong Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Li, Tianfu, et al.. (2020). Low expression of CDK12 in gastric cancer is correlated with advanced stage and poor outcome. Pathology - Research and Practice. 216(7). 152962–152962. 11 indexed citations
2.
Li, Tianfu, Huijuan Zeng, Zhen Shan, et al.. (2020). Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer. Cancer Cell International. 20(1). 100 indexed citations
3.
Zeng, Huijuan, Tianfu Li, Jiong Bi, et al.. (2020). ZNF367-induced transcriptional activation of KIF15 accelerates the progression of breast cancer. International Journal of Biological Sciences. 16(12). 2084–2093. 21 indexed citations
4.
Zhang, Qi, Si-Hong Lu, Tianfu Li, et al.. (2019). ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 173–173. 212 indexed citations
5.
Zhang, Qi, Jin Zhang, Si-Hong Lu, Nan Shao, & Ying Lin. (2019). The relationship of lncRNA NR2F1 and breast cancer angiogenesis via IL-8/lncRNA NR2F1/miR-200s/IL-8 loop.. Journal of Clinical Oncology. 37(15_suppl). e12573–e12573. 1 indexed citations
6.
Chen, Jia-Yang, Wen‐Sy Tsai, Hung‐Jen Shao, et al.. (2016). Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection. PLoS ONE. 11(3). e0149633–e0149633. 61 indexed citations
7.
Lu, Si-Hong, Wen‐Sy Tsai, Ying‐Hsu Chang, et al.. (2016). Identifying cancer origin using circulating tumor cells. Cancer Biology & Therapy. 17(4). 430–438. 54 indexed citations
8.
Tsai, Wen‐Sy, Jinn‐Shiun Chen, Hung‐Jen Shao, et al.. (2016). Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients. Scientific Reports. 6(1). 24517–24517. 134 indexed citations
9.
Shao, Hung‐Jen, et al.. (2014). Efficient elusion of viable adhesive cells from a microfluidic system by air foam. Biomicrofluidics. 8(5). 52001–52001. 20 indexed citations
10.
Tsai, Wen‐Sy, Mei‐Ying Liao, Si-Hong Lu, et al.. (2013). Antibody conjugated supported lipid bilayer for capturing and purification of viable tumor cells in blood for subsequent cell culture. Biomaterials. 34(21). 5191–5199. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026